RenovoRx Insider Trades

RNXT

Track insider trading activity from RenovoRx executives and directors. See which insiders are buying and selling RNXT stock.

Trades Last 12 Months

RNXT Price

All Insider Trades for RenovoRx

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $69.3k 55,924 shares
Last Trade
Oct 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.7k 55,924 shares
$1.55
$1.24
Ryan Una S Director
Holding Value $69.3k 55,924 shares
Last Trade
Oct 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.7k 55,924 shares
$1.55
$1.24
Marton Laurence Director
Holding Value $69.3k 55,924 shares
Last Trade
Oct 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.7k 55,924 shares
$1.55
$1.24
Holding Value $69.3k 55,924 shares
Last Trade
Oct 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.7k 55,924 shares
$1.55
$1.24
Voll Mark Chief Financial Officer
Holding Value $276k 222,380 shares
Last Trade
Sep 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 80,000 shares
$1.77
$1.24
Voll Mark Chief Financial Officer
Holding Value $177k 142,380 shares
Last Trade
May 19, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.8k 25,000 shares
$0.79
$1.24
Agah Ramtin Chief Medical Officer
Holding Value $771k 621,727 shares
Last Trade
Apr 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$609k 621,727 shares
$0.98
$1.24
Bagai Shaun Chief Executive Officer
Holding Value $1.17M 946,107 shares
Last Trade
Apr 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$927k 946,107 shares
$0.98
$1.24
Gentry Leesa Chief Clinical Officer
Holding Value $159k 128,550 shares
Last Trade
Apr 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$126k 128,550 shares
$0.98
$1.24
Ryan Una S Director
Holding Value $59.1k 47,640 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.8k 47,640 shares
$1.34
$1.24
Kocak Ron Vp, Controller And PAO
Holding Value $51.6k 41,600 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.8k 41,600 shares
$1.27
$1.24
Nelms Angela Chief Operating Officer
Holding Value $155k 125,132 shares
Last Trade
Jan 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$172k 158,900 shares
$1.08
$1.24
Diamond David Director
Holding Value $31.1k 25,099 shares
Last Trade
Oct 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.4k 25,099 shares
$1.33
$1.24
Holding Value $13.8k 11,154 shares
Last Trade
Oct 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65.9k 11,154 shares
$5.91
$1.24
Manners Paul Chief Financial Officer
Holding Value $28.9k 23,333 shares
Last Trade
Aug 25, 2021 Sale
No data
No data
$1.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up